Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroSafe Care International is a global healthcare company specializing in advanced antimicrobial and wound care solutions based on its proprietary Microcyn Technology. The company's core platform utilizes stabilized hypochlorous acid (HOCl) to develop products that are highly effective against a broad spectrum of pathogens, including bacteria, viruses, and fungi, while remaining non-toxic to human tissue. Their portfolio includes FDA-cleared and CE-marked products for wound management, dermatology, ophthalmology, and high-level surface disinfection. MicroSafe serves various sectors including hospitals, clinics, and consumer markets, providing solutions for infection prevention and accelerated tissue healing. The company is recognized for its shelf-stable, pH-neutral formulations that mimic the body's natural immune response.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroSafe Care International.